• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services


  • Print
  • Share
  • E-mail

WHO Warns Consumers in Pakistan of Risks Associated with Contaminated Medicines

Issued: Feb. 10, 2012 

FDA is aware of significant safety issues associated with medicines manufactured and distributed in Pakistan by Efroze Chemical Industries Pvt. Ltd. Since these products are not FDA approved and have not been legally imported into the United States, the Agency believes there is little likelihood of these products reaching U.S. consumers and harming the American Public. FDA will continue to monitor the situation closely and reminds the public about the possible dangers of buying medicines over the Internet. For more information about the medicines manufactured in Pakistan, see http://www.who.int/medicines/publications/drugalerts/DrugSafetyAlert125.pdf disclaimer icon .
For more information about the dangers of buying medicines over the internet, see: http://www.fda.gov/ForConsumers/ConsumerUpdates/ucm048396.htm